45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
2,477
Insurances with rates
20
CPT / HCPCS codes
2,379
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J3394 | (Lyfgenia) Lovotibeglogene Autotemcel, per Treatment | $13,392,017 | $8,704,811 | — | — | 45 |
| J3393 | (Zynteglo) Betibeglogene Autotemcel, per Treatment | $12,096,017 | $7,862,411 | — | — | 45 |
| J3392 | (Casgevy) Exagamglogene Autotemcel Hsc, per Inf | $9,504,017 | $6,177,611 | — | — | 45 |
| J3399 | ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT|DISCARDED DRUG NOT ADMINISTERED | $4,781,250 | $3,107,813 | — | — | 47 |
| J1412 | VALOCTOCOGENE ROXAPARVOVEC-RVOX 2X10EXP13 VG/ML INTRAVENOUS SUSPENSION|DISCARDED DRUG NOT ADMINISTER | $397,929 | $258,654 | — | — | 45 |
| J9029 | NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML INTRAVESICAL SUSPENSION|DISCARDED DRUG NOT ADMINISTERE | $255,780 | $166,257 | — | — | 47 |
| J9226 | Supprelin La Histrelin Implant 50 Mg | $204,840 | $133,146 | — | — | 45 |
| J9269 | INJ. TAGRAXOFUSP-ERZS 10 MCG | $141,939 | $92,260 | — | — | 94 |
| 38240 | HB Hpc Xplant Allogeneic | $122,944 | $79,914 | — | — | 47 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION|DISCARDED DRUG NOT ADMINISTERED | $117,194 | $76,176 | — | — | 47 |
| 0620T | Endovascular Venous Arterialization Tibl/Prnl Vn | $117,152 | $76,149 | — | — | 47 |
| 812 | HB Liver Acq. Fee | $116,544 | $75,754 | — | — | 16 |
| 38230 | Nmdp Primary Bone Marrow Collection | $114,333 | $74,316 | — | — | 46 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION|DISCARDED DRUG NOT ADMINISTERED | $112,624 | $73,205 | — | — | 47 |
| J9348 | NAXITAMAB-GQGK 4 MG/ML INTRAVENOUS SOLUTION | $109,638 | $71,265 | — | — | 47 |
| 815 | Nmdp Primary Cord Blood Collection | $108,956 | $70,821 | — | — | 14 |
| J9281 | MITOMYCIN 40 MG X 2 INTRA-PYELOCALYCEAL KIT|DISCARDED DRUG NOT ADMINISTERED | $104,769 | $68,100 | — | — | 47 |
| J1303 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION | $101,169 | $65,760 | — | — | 47 |
| 811 | Renal Live Acquisition | $92,263 | $59,971 | — | — | 16 |
| J0638 | CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION | $89,865 | $58,412 | — | — | 47 |
| J1961 | LENACAPAVIR 309 MG/ML SUBCUTANEOUS SOLUTION (SUNLENCA) | $81,917 | $53,246 | — | — | 47 |
| J7311 | INJ., RETISERT, 0.01 MG | $79,922 | $51,949 | — | — | 47 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $78,329 | $50,914 | — | — | 47 |
| C1822 | Nevro Senza Omnia Ipg Kit | $76,914 | $49,994 | — | — | 13 |
| J3241 | INJ. TEPROTUMUMAB-TRBW 10 MG | $76,255 | $49,565 | — | — | 47 |
| C1826 | GEN, NEURO, CLO LOOP, RECHG | $76,028 | $49,418 | — | — | 30 |
| J3245 | TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE | $75,455 | $49,046 | — | — | 47 |
| C1767 | Stj Mn10200 Axium Ipg Neurostimulator | $71,440 | $46,436 | — | — | 13 |
| J9321 | EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION | $69,378 | $45,096 | — | — | 47 |
| J9334 | EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11,200 UNIT/5.6 ML SUBCUT SOLN|DISCARDED DRUG NOT ADMINISTER | $68,923 | $44,800 | — | — | 47 |
| C1820 | Stj 3771/3730 Protege Ipg W/Rechg System | $65,651 | $42,673 | — | — | 13 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $64,933 | $42,207 | — | — | 47 |
| J9026 | TARLATAMAB-DLLE 10 MG INTRAVENOUS SOLUTION | $63,161 | $41,055 | — | — | 47 |
| C1722 | AICD, SINGLE CHAMBER | $62,111 | $40,372 | — | — | 13 |
| J9381 | TEPLIZUMAB-MZWV 1 MG/ML INTRAVENOUS SOLUTION | $61,788 | $40,162 | — | — | 47 |
| J3357 | USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SYRINGE | $61,235 | $39,803 | — | — | 36 |
| J1628 | GUSELKUMAB 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION|DISCARDED DRUG NOT ADMINISTERED | $61,179 | $39,766 | — | — | 47 |
| C1721 | AICD, DUAL CHAMBER | $59,627 | $38,758 | — | — | 39 |
| 33947 | Ecls Initial Veno-Arterial | $59,452 | $38,644 | — | — | 29 |
| J9316 | PERTUZUMAB 1,200 MG-TRASTUZUMAB 600 MG-HYALURON-ZZXF/15 ML SUBCUT SOLN | $58,610 | $38,097 | — | — | 47 |
| C1786 | System Micra Av Transcatheter Pacing | $54,926 | $35,702 | — | — | 13 |
| J1305 | EVINACUMAB-DGNB 150 MG/ML INTRAVENOUS SOLUTION|DISCARDED DRUG NOT ADMINISTERED | $54,032 | $35,121 | — | — | 94 |
| 33249 | HB Icd Insert New/Replacement System | $53,567 | $34,819 | — | — | 47 |
| J3285 | TREPROSTINIL INJECTION | $53,530 | $34,795 | — | — | 188 |
| 819 | HB Pancreas Export Fee | $53,500 | $34,775 | — | — | 13 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $53,399 | $34,710 | — | — | 47 |
| C2622 | PROSTHESIS, PENILE, NON-INF | $52,145 | $33,894 | — | — | 26 |
| 93653 | Ep Eval&Ablate Arrhythmia,Tx Supraventricular Tach, Art | $51,956 | $33,771 | — | — | 47 |
| J9272 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $50,688 | $32,947 | — | — | 47 |
| J0567 | CERLIPONASE ALFA 150 MG/5 ML INTRAVENTRICULAR SOLUTION|DISCARDED DRUG NOT ADMINISTERED | $50,224 | $32,646 | — | — | 47 |
Showing top 50 of 2,477 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.